MEC Plus Full List View

MEC Plus

EGFR-Mutated Lung Cancers
EGFR-Mutated Lung Cancers
Collin Blakely, MD, PhD
Immunotherapy
Immunotherapy
David R. Gandara, MD.
Follicular Lymphoma: Novel Advances and Pathways
Follicular Lymphoma: Novel Advances and Pathways
Nahkle Saba, MD
DLBCL & Hodgkin’s Disease: Novel Approaches
DLBCL & Hodgkin’s Disease: Novel Approaches
Eduardo Sotomayor, MD
T-Cell NHL: What’s New?
T-Cell NHL: What’s New?
Francine M. Foss, MD
Anticoagulation in the Oncology Patient
Anticoagulation in the Oncology Patient
Pamela Dudkiewicz, ARPN
CLL: Novel Therapies
CLL: Novel Therapies
Javier Pinilla-Ibarz, MD
Myeloma, So Many Therapeutic Options in the Relapse Setting: How to Sequence Them?
Myeloma, So Many Therapeutic Options in the Relapse Setting: How to Sequence Them?
Jonathan Kaufman, MD
Myelodysplasia: Biomarkers, Risk Assessment and Novel Treatments
Myelodysplasia: Biomarkers, Risk Assessment and Novel Treatments
Rami Komrokji, MD
Chimeric Antigen Receptor T-Cell Therapy: Indications and Remaining Challenges
Chimeric Antigen Receptor T-Cell Therapy: Indications and Remaining Challenges
Mohamed Kharfan-Dabaja, MD
De Novo Acute Myeloid Leukemia
De Novo Acute Myeloid Leukemia
Hugo Fernandez, MD
New Agents and New Toxicities in Malignant Hematology: BCL2 Inhibitors, Anti-BCMA, and FLT3 Inhibitors
New Agents and New Toxicities in Malignant Hematology: BCL2 Inhibitors, Anti-BCMA, and FLT3 Inhibitors
Nicole Ianniello, PharmD
RET, MET & B-RAF mutations in NSCLC
RET, MET & B-RAF mutations in NSCLC
Janakiraman Subramanian, MD, MPH
ERBB2 and NGR1 Pathways in NSCLC
ERBB2 and NGR1 Pathways in NSCLC
Estelamari Rodriguez, MD
ALK, ROS1 & NTRK Mutations in NSCLC
ALK, ROS1 & NTRK Mutations in NSCLC
Corey Langer, MD
EGFR and K-RAS Mutations in NSCLC
EGFR and K-RAS Mutations in NSCLC
Edgardo S. Santos Castillero, MD
Lung Cancer Clinical Scenarios: How Liquid Biopsy Technology Is Delivering Personalized Therapy in NSCLC
Lung Cancer Clinical Scenarios: How Liquid Biopsy Technology Is Delivering Personalized Therapy in NSCLC
Christian Rolfo, MD
Adjuvant and Neoadjuvant Novel Concepts and Strategies in NSCLC
Adjuvant and Neoadjuvant Novel Concepts and Strategies in NSCLC
David Gandara, MD
Small Cell Lung Cancer: After Immunochemotherapy, What’s Next?
Small Cell Lung Cancer: After Immunochemotherapy, What’s Next?
Paul Bunn, MD
Integrative Oncology in Cancer Care
Integrative Oncology in Cancer Care
Ashwin Mehta, MD
Thyroid Cancer & Thymic Carcinoma: Recent Advances
Thyroid Cancer & Thymic Carcinoma: Recent Advances
Raja Mudad, MD
Metastatic Cancer Survivorship Care
Metastatic Cancer Survivorship Care
Adrienne M. Vazquez Guerra, MSN, ACNP-BC, AOCN
Neuroendocrine Tumors (NET): Novel Advances in Therapy
Neuroendocrine Tumors (NET): Novel Advances in Therapy
Pasquale W. Benedetto, MD
Castration Resistant Prostate Cancer (CRPC), Non-Metastatic & Metastatic: Novel Therapeutic Advances
Castration Resistant Prostate Cancer (CRPC), Non-Metastatic & Metastatic: Novel Therapeutic Advances
Michael Hurwitz, MD, PhD